Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | GAA | P10253 | 3/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | NAMPT | P43490 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | PTPRC | P08575 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2351707 | 0.89 | RAB9A (0.70) | RAB9AKMT2AGAANPC1ALDH1A1 | |
| SCHEMBL839259 | 0.83 | RAB9A (0.63) | RAB9AKMT2ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2349758 | 0.83 | NAMPT (0.70) | RAB9AKMT2AGAANPC1ALDH1A1 | |
| SCHEMBL829868 | 0.82 | RAB9A (0.69) | RAB9AKMT2ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2939045 | 0.82 | RAB9A (0.60) | RAB9AKMT2AGAANPC1ALDH1A1 | |
| SCHEMBL2003113 | 0.82 | NAMPT (0.62) | RAB9AKMT2AGAANPC1ALDH1A1 | |
| SCHEMBL839348 | 0.80 | NAMPT (0.66) | RAB9AKMT2ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL8864260 | 0.79 | SMN1; SMN2 (0.69) | RAB9AKMT2ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2352185 | 0.79 | GAA (0.59) | RAB9AKMT2AGAANPC1ALDH1A1 | |
| SCHEMBL1931512 | 0.79 | NAMPT (0.65) | RAB9AGAANPC1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110313057-A1 | DIFUNCTIONALIZED AROMATIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2011-12-22 | — | — | US | disclosed |
| US-20110313057-A1 | DIFUNCTIONALIZED AROMATIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2011-12-22 | — | — | US | disclosed |
| US-20110313057-A1 | DIFUNCTIONALIZED AROMATIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2011-12-22 | — | — | US | disclosed |
| US-8007526-B2 | Difunctionalized aromatic compounds and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2011-08-30 | — | — | US | disclosed |
| US-8007526-B2 | Difunctionalized aromatic compounds and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2011-08-30 | — | — | US | disclosed |
| US-8007526-B2 | Difunctionalized aromatic compounds and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2011-08-30 | — | — | US | disclosed |
| US-20070129787-A1 | DIFUNCTIONALIZED AROMATIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2007-06-07 | — | — | US | disclosed |
| US-20070129787-A1 | DIFUNCTIONALIZED AROMATIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2007-06-07 | — | — | US | disclosed |
| US-20070129787-A1 | DIFUNCTIONALIZED AROMATIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313057-A1 | DIFUNCTIONALIZED AROMATIC COMPOUNDS AND POLYMERS THEREFROM | AHR, OGFR, OPRM1 | RAB9A 3302/4885KMT2A 3072/4885GAA 2261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.